Injective vs Anoma — how do they compare? Injective trades at Rp76,507 (market cap Rp7,62T, Rp1,05T 24h volume), while Anoma trades at Rp193.55 (market cap Rp481,15M, Rp58,6M 24h volume). The key difference: Injective is far larger — about 15837.1× Anoma's market cap, and Anoma's supply is capped (2,5B / 10B XAN (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Anoma for 4 Days on average.
| INJ | XAN | |
|---|---|---|
Market Cap | Rp7,62T | Rp481,15M |
Volume (24h) | Rp1,05T | Rp58,6M |
Circulating Supply | 100M INJ | 2,5B / 10B XAN (25%) |
Typical Hold Time | 37 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Anoma (XAN) currently trades at Rp202.22 with a market cap of Rp507.15M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 25% circulating supply with 4-day average hold time. Current price sits near the pivot point of Rp197, with immediate resistance at Rp204 and support at Rp191. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity, limited exchange presence, and typical crypto volatility. Investors should monitor for any ecosystem developments that could drive adoption.
What Pluang investors did over the last 30 days
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Anoma is a decentralized operating system that enables developers to build a single app that can run on any blockchain. Its intent-centric architecture simplifies infrastructure complexity, improving development efficiency and user experience. Anoma supports a unified app layer that brings Web3 app functionality closer to Web2 usability.
Read more on XAN →